paroxetine/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases subjective fatigue
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“Fatigue scores improved significantly in both groups, but the reduction was larger in the paroxetine group [7.75 (6.9–8.52) → 4.5 (3.27–7.27)] compared to the control group [7.55 (7–8.4) → 5.85 (4.57–8.25); p = 0.006 between groups].”
Quoted verbatim from Efficacy of Paroxetine as an Adjuvant Therapy in Rheumatoid Arthritis Patients: A Randomized Controlled Study.. - Study
- RCT
- Duration
- 3 months
- Dose
- paroxetine 20 mg once daily
- Population
- Adults with active mild or moderate rheumatoid arthritis, all on methotrexate-based csDMARDs and prednisolone 10 mg/day in both arms; paroxetine plus csDMARD versus placebo plus csDMARD; three-month result, intention-to-treat with baseline observation carried forward
Efficacy of Paroxetine as an Adjuvant Therapy in Rheumatoid Arthritis Patients: A Randomized Controlled Study.2025PMID:41488752Permalink
Keep reading
- Everything the graph holds on paroxetine
- Every compound studied against Subjective fatigue
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M45E7A889QC3X9GHVYHAJFRN